Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
RPTH Journal shared on LinkedIn:
”How to manage VTE in patients with peripheral arterial disease
Patients with peripheral arterial disease routinely receive antithrombotic therapy, yet the optimal management of a VTE in this population remains uncertain.
Using nationwide Dutch data , this study highlights substantial variability in real-world practice and underscores the need for clear guidance and consensus in this complex clinical scenario.
Read the full article here.”
Article: Antithrombotic therapy in lower extremity peripheral artery disease patients with venous thromboembolism: a nationwide cohort study
Authors: Jamilla Goedegebuur, Elena Butera, Qingui Chen, Behnood Bikdeli, Walter Ageno, Roberto Pola, Angelo Porfidia, Stefano Barco, Thijs E. van Mens, Joost R. van der Vorst, Suzanne C. Cannegieter, Frederik
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis